SARS-CoV-2 Seroprevalence in Aden, Yemen a Population-Based Study. Preprint
GHDx Entry last modified on: May 12, 2022
Blood tests
Dataset Records for Blood tests
Displaying 201 - 250 of 1718
Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium - a serial prospective cross-sectional nationwide study of residual samples. Preprint
Scientific literature:
Cross-sectional
Seroprevalence of SARS-CoV-2 in Palestine: a cross-sectional seroepidemiological study. Preprint.
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals. Preprint
GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany
GHDx Entry last modified on: Jan 31, 2024
Increased Mask Use and Fewer Gatherings Associated with Lower SARS-CoV-2 Seropositivity Among Young School-Age Children. Preprint
GHDx Entry last modified on: Mar 14, 2022
Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study. Preprint
GHDx Entry last modified on: May 12, 2022
A translational multiplex serology approach to profile the prevalence of anti-SARS-CoV-2 antibodies in home-sampled blood. Preprint
GHDx Entry last modified on: Mar 14, 2022
A population-based seroprevalence survey of severe acute respiratory syndrome coronavirus 2 infection in Beijing, China. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of antibodies against SARS-CoV-2 among public community and health-care workers in Alzintan City of Libya. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in Wuhan City and other places of China
GHDx Entry last modified on: Jan 31, 2024
High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo
GHDx Entry last modified on: Jan 31, 2024
COVID Seroprevalence, Symptoms and Mortality During the First Wave of SARS-CoV-2 in Canada
GHDx Entry last modified on: May 12, 2022
Population-Based Study of anti-SARS-CoV-2, Social Distancing and Government Responses in Joinville, Brazil. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and seroconversion rates to SARS-CoV-2 in interns, residents, and medical doctors in a University Hospital in Bogota, Colombia. Preprint
GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance. Preprint.
GHDx Entry last modified on: May 12, 2022
Lessons from low seroprevalence of SARS-CoV-2 antibodies in schoolchildren: A cross-sectional study
GHDx Entry last modified on: Jun 17, 2021
Seroprevalence of anti-SARS-COV-2 antibodies in blood donors from Nuevo Leon state, Mexico, during the beginning of the COVID-19 pandemic. Preprint
GHDx Entry last modified on: Mar 14, 2022
Coronavirus antibody screening identifies children with mild to moderate courses of PMIS
GHDx Entry last modified on: Mar 14, 2022
Prevalence evolution of SARS-CoV-2 infection in the Municipality of São Paulo, 2020 - 2021
GHDx Entry last modified on: May 12, 2022
High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behavior measures: Results from the DETECTCoV-19 cohort. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2, symptom profiles and seroneutralization during the first COVID-19 wave in a suburban area, France. Preprint
GHDx Entry last modified on: Mar 14, 2022
Armenia Integrated Living Conditions Survey 2020
Survey:
Household - Interview - Urban-rural representative
High SARS-CoV-2 Seroprevalence in Children and Adults in the Austrian Ski Resort Ischgl. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early months of the pandemic in Saudi Arabia
GHDx Entry last modified on: Jun 17, 2021
Lack of Antibodies to SARS-CoV-2 among Blood Donors during COVID-19 Lockdown: A Study from Saudi Arabia
GHDx Entry last modified on: Mar 14, 2022
Charting Elimination in the Pandemic: A SARS-CoV-2 Serosurvey of Blood Donors in New Zealand. Preprint
GHDx Entry last modified on: Mar 14, 2022
Findings from serological surveys (in August 2020) to assess the exposure of adult population to SARS Cov-2 infection in three cities of Odisha, India. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Temporal trends of SARS-CoV-2 seroprevalence in transfusion blood donors during the first wave of the COVID-19 epidemic in Kenya
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 has been circulating in northeastern Brazil since February 2020: evidence for antibody detection in asymptomatic patients
GHDx Entry last modified on: Mar 14, 2022
Surveillance and Seroprevalence: Evaluation of IgG antibodies for SARS-Cov2 by ELISA in the popular neighborhood Villa Azul, Quilmes, province of Buenos Aires, Argentina. Preprint
GHDx Entry last modified on: Mar 14, 2022
Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign
GHDx Entry last modified on: Jan 31, 2024
Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich. Preprint
GHDx Entry last modified on: Mar 14, 2022
Contrasting SARS-CoV-2 epidemics in Singapore: Cohort studies in migrant workers and the general population. Preprint
GHDx Entry last modified on: Mar 14, 2022
Estimation of real-infection and immunity against SARS-CoV-2 in Indian populations. Preprint
GHDx Entry last modified on: Apr 8, 2022
COVID-Inconfidentes - SARS-CoV-2 seroprevalence in two Brazilian urban areas during the pandemic first wave: study protocol and initial results. Preprint
GHDx Entry last modified on: Mar 14, 2022
Benin Health Statistical Yearbook 2020
Annuaire des Statistiques Sanitaires 2020
Report:
Epi surveillance - Subnationally representative - Urban-rural representative
Niger Health Statistical Yearbook 2020
Annuaire Des Statistiques Sanitaires Niger, 2020
Report:
Epi surveillance - Subnationally representative
[Prevalence of ABO and Rh Blood groups in the city of Quito-Ecuador]
Prevalencia de los grupos sanguíneos ABO y Rh en la ciudad de Quito- Ecuador
Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India
GHDx Entry last modified on: Jan 31, 2024
Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020
GHDx Entry last modified on: Jan 31, 2024
Sentinel seroprevalence of SARS-CoV-2 in the Gauteng province, South Africa August to October 2020. Preprint
GHDx Entry last modified on: May 12, 2022
Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China
GHDx Entry last modified on: Jan 31, 2024
Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study
GHDx Entry last modified on: Mar 14, 2022
Longitudinal SARS-CoV-2 seroprevalence in a rural and urban community household cohort in South Africa, during the first and second waves July 2020-March 2021. Preprint
GHDx Entry last modified on: May 12, 2022
Saint Lucia STEPS Noncommunicable Disease Risk Factors Survey 2019-2020
Survey:
Cross-sectional - Individual - Interview
Social Determinants of Health and Risk of SARS-CoV-2 Infection in Community-Dwelling Older Adults Living in a Rural Latin American Setting
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 in rural Latin America. A population-based study in coastal Ecuador
GHDx Entry last modified on: Mar 14, 2022
Rwanda Demographic and Health Survey 2019-2020
Survey:
Cross-sectional - Household - Individual - Nationally representative - Urban-rural representative
Subscribe